- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Strides Pharma Science Limited — Updates, 31-10-2025: Press Release
31-10-2025 | 01:00 pm
31-10-2025 | 01:00 pm
Strides Pharma delivered robust Q2FY26 financial results: Operational PAT soared 84% YoY to ₹140.3 Cr, with EPS at ₹15.2. Revenue grew 4.6% and EBITDA 25.4% YoY, alongside improved margins. Net debt reduced by ₹46.9 Cr sequentially, affirming strong financial discipline.
No comments yet. Be the first to comment!